The AESKULISA Parvovirus B19 IgM is a qualitative and quantitative immunoassay for the demonstration of human IgM antibodies in serum or plasma directed against Parvovirus B19. The AESKULISA Parvovirus B19 IgM is recommended for the detection of acute infections.
Virus-like Particels (VLPs) composed of recombinant VP2 produced in baculovirus-infected insect cells
n.a.
AESKU.GROUP位于德国温德尔斯海姆,是一家致力于研究,提供创新和高效产品和服务的研究型供应商,用于早期发现,诊断和预后自身免疫性疾病。
自AESKU.DIAGNOSTICS于2000年成立以来仅十年,就在自身免疫领域广受认可,在全球90多个国家/地区推出了150多种产品以及不间断的服务。